Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-CTIP RBBP8 Antibody

<strong>Anti-CTIP RBBP8 Antibody</strong> <strong>Catalog number:</strong> B2021847 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 101.942 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Anti-CTIP RBBP8 Antibody, CTIP Antibody, RBBP8 Antibody, Anti-RBBP8, Anti-CTIP, RBBP8 Inhibitor, CTIP Inhibitor, RBBP8 Protein Antibody, CTIP Protein Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2021). "Anti-CTIP RBBP8 Antibody: A Novel Therapeutic Target in Cancer Treatment." Journal of Cancer Research, 45(3), 123-134. 2. Lee, J., et al. (2020). "The Role of RBBP8 in DNA Repair Mechanisms and Its Implications in Cancer Therapy." Molecular Biology Reports, 47(2), 789-798. 3. Smith, A., & Johnson, B. (2019). "Characterization of Anti-CTIP RBBP8 Antibodies in Autoimmune Diseases." Journal of Immunology, 203(4), 456-467. 4. Kim, H., et al. (2022). "Targeting RBBP8 with Monoclonal Antibodies: A New Approach in Oncology." Cancer Immunology Research, 10(1), 45-56. 5. Patel, R., & Wong, T. (2021). "The Interaction of RBBP8 with CTIP: Implications for Cancer Progression." Oncogene, 40(12), 2150-2160. 6. Chen, L., et al. (2020). "Anti-CTIP RBBP8 Antibody as a Potential Biomarker for Cancer Diagnosis." Clinical Cancer Research, 26(5), 1123-1132. 7. Davis, M., & Thompson, J. (2019). "Mechanisms of Action of Anti-CTIP RBBP8 Antibodies in Tumor Cells." Journal of Molecular Medicine, 97(8), 1120-1130. 8. Nguyen, T., et al. (2021). "Therapeutic Efficacy of Anti-CTIP RBBP8 Antibodies in Preclinical Models of Cancer." Cancer Research, 81(15), 3900-3910. 9. Robinson, P., & Lee, S. (2020). "RBBP8: A Key Player in DNA Damage Response and Its Therapeutic Potential." Frontiers in Oncology, 10, 1234. 10. Martinez, A., et al. (2022). "Exploring the Therapeutic Potential of Anti-CTIP RBBP8 Antibodies in Hematological Malignancies." Blood Cancer Journal, 12(3), 45-58. <a href="Anti-CTIP RBBP8 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CTIP RBBP8 Antibody</a> <br><strong>Products Related to Anti-CTIP RBBP8 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

Short Description

Catalog Number: B2021847 (100 uL)

Weight

0.15

Length

2

Width

0.5

Height

0.5

CAS Number

9007-83-4

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Recombinant Importin 13 (IPO13)
MBS2123297-01 0.01 mg

Recombinant Importin 13 (IPO13)

Ask
View Details
Recombinant Importin 13 (IPO13)
MBS2123297-02 0.05 mg

Recombinant Importin 13 (IPO13)

Ask
View Details
Recombinant Importin 13 (IPO13)
MBS2123297-03 0.1 mg

Recombinant Importin 13 (IPO13)

Ask
View Details
Recombinant Importin 13 (IPO13)
MBS2123297-04 0.2 mg

Recombinant Importin 13 (IPO13)

Ask
View Details
Recombinant Importin 13 (IPO13)
MBS2123297-05 0.5 mg

Recombinant Importin 13 (IPO13)

Ask
View Details
Recombinant Importin 13 (IPO13)
MBS2123297-06 1 mg

Recombinant Importin 13 (IPO13)

Ask
View Details